GENOCEA BIOSCIENCES INC by Genocea Biosciences, Inc. (GNCAQ) Stock Price, Quote, News & History

GNCAQOTCEM

Trade with Public

$0.000001

N/A

At close: May 15, 5:00 PM EST

OverviewShort Interest

Key Statistics

Open

$0.00

Volume / Avg.

0 / 4.20K

Day Range

- - -

52 Wk Range

0.00 - 0.00

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

999.99

Recent Genocea Biosciences Inc News

No news found

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-48.19M

Investing Cash Flow (TTM)

-3.10M

Financing Cash Flow (TTM)

5.39M

Free Cash Flow (TTM)

-51.33M

Capital Expenditure (TTM)

-3.14M

Net Change in Cash (TTM)

-45.90M

Valuation Metrics

Enterprise Value

-$4.65M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

Earnings Yield % (TTM)

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

Company Debt

Total Debt

$7.65M

LT Debt

$2.95M

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

-$2.50M

Total Cash

$20.14M

Debt to Equity

1.25

Issuance of Debt (TTM)

-$2.50M

Repayment of Debt (TTM)

-$2.50M

Key Statistics

Open

$0.00

Volume / Avg.

0 / 4.20K

Day Range

- - -

52 Wk Range

0.00 - 0.00

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

999.99

About

Sector

Health Care

Industry

Biotechnology

Genocea Biosciences Inc is a USA-based biopharmaceutical company discovering and developing novel cancer immunotherapies using its proprietary ATLAS platform. The ATLAS platform can profile each patient's CD4+ and CD8+ T cell immune responses to ever...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy GENOCEA BIOSCIENCES INC by Genocea Biosciences, Inc. (GNCAQ) stock?

You can purchase shares of GENOCEA BIOSCIENCES INC by Genocea Biosciences, Inc. (OTCEM:GNCAQ) through any online brokerage.

View our list of the best stock brokerages

Who are GENOCEA BIOSCIENCES INC by Genocea Biosciences, Inc. (GNCAQ) competitors?

There are no as such competitors for GENOCEA BIOSCIENCES INC by Genocea Biosciences, Inc..

What is the forecast, or price target, for GENOCEA BIOSCIENCES INC by Genocea Biosciences, Inc. (GNCAQ) stock?

There is no analysis for GENOCEA BIOSCIENCES INC by Genocea Biosciences, Inc. to provide a consensus price target.

What is the current price for GENOCEA BIOSCIENCES INC by Genocea Biosciences, Inc. (GNCAQ)?

The stock price for GENOCEA BIOSCIENCES INC by Genocea Biosciences, Inc. (OTCEM: GNCAQ) is $0.000001 last updated May 18, 2026 at 10:47 AM EDT.

Does GENOCEA BIOSCIENCES INC by Genocea Biosciences, Inc. (GNCAQ) pay a dividend?

There are no upcoming dividends for GENOCEA BIOSCIENCES INC by Genocea Biosciences, Inc..

When is GENOCEA BIOSCIENCES INC by Genocea Biosciences, Inc. (OTCEM:GNCAQ) reporting earnings?

GENOCEA BIOSCIENCES INC by Genocea Biosciences, Inc. does not have any upcoming earnings scheduled.

Is GENOCEA BIOSCIENCES INC by Genocea Biosciences, Inc. (GNCAQ) going to split?

There is no upcoming split for GENOCEA BIOSCIENCES INC by Genocea Biosciences, Inc..

What sector and industry does GENOCEA BIOSCIENCES INC by Genocea Biosciences, Inc. (GNCAQ) operate in?

GENOCEA BIOSCIENCES INC by Genocea Biosciences, Inc. is in the Health Care sector and Biotechnology industry. They are listed on the OTCEM.